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Volume 53, Number 1 Letters to the Editor 263MEDLINE and EMBASE, were searched from January 1995 to
May 2010 using Web-based search engines (PubMed and OVID)
with exploding keywords including sex, gender, rupture, ruptured,
and abdominal aortic aneurysm. Studies considered for inclusion
met the following criteria: the study population was patients un-
dergoing repair of ruptured AAA; main outcomes included ad-
justed ORs for 30-day or in-hospital death among women com-
pared with men; and the adjusted method was appropriate (eg,
multivariate logistic regression). We excluded studies providing
merely unadjusted mortality or ORs.
Our search identified eight studies, including the study by
Mureebe et al,1 that provided adjustedORs for perioperative death
among women compared with men in repair of ruptured AAA.
Pooled analysis (representing 164,883 patients) demonstrated a
statistically significant increase in perioperative mortality among
women compared with men in the random effects model (pooled
adjusted OR, 1.28; 95% CI, 1.11-1.47; P  .0005; Fig). There was
significant between-study heterogeneity (P  .00001) and little dif-
ference in the pooled result from the fixed-effects model (pooled
adjusted OR, 1.19; 95% CI, 1.17-1.22; P  .00001). Exclusion of
any single study from the analysis did not substantively alter the overall
result of our analysis. There was no evidence of significant publication
bias (P .60 by an adjusted rank-correlation test).
The results of our analysis suggest that female gender is
associated with increased risk of perioperative death in repair of
ruptured AAA, which was robust in sensitivity analyses and
strengthens the conclusion of the study by Mureebe et al.1
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This is in response to the letter by Doctors Takagi, Manabe,
Matsui, Goto, and Umemoto, entitled “Regarding ‘Gender trends
in the repair of ruptured abdominal aortic aneurysms and out-
comes’”. The authors evaluated the contemporary literature exam-
ining the risk of death from ruptured abdominal aortic aneurysms
(AAAs). The authors both utilized and compared these results to
our recently published article in the Journal of Vascular Surgery.
We are very appreciative of their work and of their findings, which
further cement our conclusion that female gender is associated
with increased risk of perioperative death after repair of a ruptured
AAA. This conclusion endures, even in the setting of significant
heterogeneity in the studies the authors examined, furthering this
as a universal outcome. As we commented on in our discussion,
administrative databases are limited to the ability to dissect out the
underlying explanations of this observed difference in mortality
from ruptured AAA between men and women.
We thank the authors for their comments and for their efforts
in continuing to highlight differences in outcomes. We are hopeful
that additional research will expose the bases of this worrisome
observation.
Leila Mureebe, MD
Duke University Medical Center
Durham, NC
doi:10.1016/j.jvs.2010.07.047
Regarding “Analysis of risk factors for abdominal aortic
aneurysm in a cohort of more than 3 million individuals”
We read with interest the article by Kent et al1 in the Septem-
ber 2010 issue of the Journal of Vascular Surgery. These important
data add to our understanding the risk factors for abdominal aortic
aneurysms (AAAs), which have come from large screening trials
and a smaller number of prospective population studies.2-4 We
would, however, like to make some points regarding the potential
translation of the predictive score set out by the authors. The
overall prevalence of AAAs in patients screened by life line screen-
ing appears to be extremely low (0.8%) when compared to other
data sets. This may be a reflection of the fact that the screened
population was a healthier group than the general population
(referred to by the authors in the discussion), and if this is the case,
then the odds ratios generated by the analysis are likely to be falsely
elevated when extrapolated to the general population. Perhaps this
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EVRis why the authors attempted to predict prevalence in the popula-
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Examination Survey cohort rather than the more obvious extrap-
olation of data from the life line screening cohort.
This point demonstrates that robust predictive scores for
complex diseases should be based on data generated from longitu-
dinal population studies rather than selected cohorts such as this.
In addition, the majority of any individuals’ risk based on this score
that is explained by their age and smoking history, is the current
standard for selective screening in the United States. Virtually all of
the domains in the scoring system are related to atherosclerosis,
which may not be a causal process in AAAs and, therefore, may be
overrepresented in the score.5
Finally, the authors equate the efficiency of screening to the
prevalence of the disease in screened groups (number of screens per
AAA), but this is only one part of the cost-effectiveness equation. The
prognosis for aneurysmal disease is reduced in smokers and patients
with a high prevalence of cardiovascular disease, whichmay negatively
impact upon the cost-effectiveness of screening this group.6,7
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We thank the authors of this Letter to the Editor for sharing
their interesting comments on our study. In this letter, it is
suggested that the prevalence of abdominal aortic aneurysms
(AAAs) in our data set is lower than the prevalence observed in
other data sets, in that it reflects the provenance of our cohort from
an overall healthier population. Based on this observation, the
authors of the letter infer that the odds ratio derived from the
analysis of risk factors in our sample could be inflated when
extrapolated to the general population.
The discrepancy between the prevalence in our cohort and the
prevalence reported by other studies is mostly a consequence of the
high representation (64.7%) of women in our cohort, which on
average have a lower risk of AAAs as compared tomen.Other studies,
which report a prevalence of AAA around 4%, aremostly composed of
men. TheMulticentre Aneurysm Screening Study study, for example,
included only male subjects, and in the cohort of veterans from theAneurysm Detection and Management study, the proportion of
womenwas only 2.6%.1 In the subset of our cohort composed ofmale
subjects aged 65 to 79 years old, the prevalence of an AAA is 2.8%, a
figure more comparable to previously reported prevalence data.
Nonetheless, as we indicated in the discussion, we do not exclude the
possibility that our sample could be derived from a somewhat health-
ier group of people. However, this alone would not result in falsely
elevated odds ratios.Our cohort included a broad spectrumof specific
risk factors whose strength of association with AAA disease, as mea-
sured by the odds ratio, would not be affected if subjects at risk
were under-represented in the cohort.
Becausewe assumed thatwe could extrapolate the strengthof the
association between risk factors and disease to the general population,
but not the actual distribution of risk factors, we used estimates of risk
factors’ prevalence from theNationalHealth andNutrition Examina-
tion Survey dataset. By combining prevalence and distribution of risk
factors derived from National Health and Nutrition Examination
Survey with our estimates of the strength of association between risk
factors andAAA,wewere able tomake predictions of AAAprevalence
in the general population. We fully agree that, ideally, predictive
scores should be derived from longitudinal population studies. How-
ever, data sources based on longitudinal samples that are large enough
to enable robust predictions in different population subgroups do not
currently exist. The life line screening data set is a very rich data set
which permits to derive useful inferences about the relationship be-
tween risk factors and AAA disease, and that we believe have adjusted
sufficiently for potential selection bias. The resulting predictive score
clearly needs to be validated in another cohort with the aim of
generating the definitive risk prediction model.
As indicated by the authors of the Letter to the Editor, our
data are in line with current recommendations, by indicating that
age and smoking history along with male sex, are the most impor-
tant risk factors. However, current recommendations treat smok-
ing as a binary variable, even though it encompasses a broad
spectrum of risk that depends on differences in individual smoking
history. We have shown that the inclusion of smoking patterns
along with additional risk factors greatly enhances the efficiency of
selective screening as compared to current recommendations. Sim-
ilarly, the accuracy of our predictive model is enhanced by the
inclusion of additional risk factors, atherosclerosis-related and not.
The impact of each of these risk factors was fully adjusted for the
impact of the other risk factors. This is independent from the
nature of the relationship between atherosclerosis and AAA, which
cannot be clarified by multivariable analysis.
Finally, the authors of the letter are right in pointing out that
increasing the efficiency in the detection of AAA does not neces-
sarily translate in a more cost-effective screening program, given
the different prognoses and life expectancies of selected subjects
and the potential induced costs generated by the new selection
criteria. A cost-effectiveness analysis of the implementation of our
score is warranted and is a relevant next step, but it was beyond the
scope of this article.
Thank you again for stimulating a discussion on these impor-
tant issues.
Giampaolo Greco, PhD, MPH
Mount Sinai School of Medicine
Health Evidence and Policy
New York, NY
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